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The diversity oflymphocytes was first identified in 1968 (1), with the realiza-
tion that B cells, responsible for antibody production, could be separated from
T cells, which are responsible for delayed-type hypersensitivity (DTH),' cytotox-
icity, and regulation of immune functions. Subset-specific surface antigens sub-
sequently allowed the division of T cells into two classes: T cells bearing Lyt-1
(2) and L3T4(3) antigens areresponsible for helper and DTH functions, whereas
cytotoxicity and suppression are predominantly mediated by T cells bearing the
Lyt-2 antigen. Several studies have since indicated that the L3T4+ (CD4+)
helper/DTH T cell population could be further subdivided into at least two
subtypes (4-11), based on functional criteria. Recently, we and others have
shown that CD4+ T cell clones grown in vitro can be divided into at least two
groups, based on the type of help provided to B cells (12) or the pattern of
lymphokines secreted after antigen or Con A stimulation (13). The lymphokines
secreted only by the first type ofclone, T helper 1 (Thl) were IL-2 and IFN-7,
whereas only Th2 clones secreted IL-4 (13). Recently, we have also shown that
only the Thl clones, producing IL-2 and IFN-'y, are capable of producing an
antigen-specific swelling reaction with the characteristics ofDTH (14). A similar
division may exist in the rat, since the CD4+,0X22+ population is responsible
for most IL-2 production, whereas the CD4+,0X22- population is responsible
for the majority of B cell help (15).
The bioassays used to detect most, ifnot all lymphokines, are now known to
be very complex. Assay cell lines typically respond to more than one lymphokine,
and there are often positive or negative interactions between the activities of
differentlymphokines. Inaddition, many lymphokines have effects on more than
one cell type. These complexities mean that rigorously monospecific bioassays
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for lymphokines are difficult to establish, and for several T cell products we do
not yet have sufficient information to produce monospecific functional assays.
To further analyze the production of various induced proteins of Th l and
Th2 clones, we have turned to the analysis of mRNA by cytoplasmic dot
hybridization (16) as an alternative method to evaluate differences between the
T cell clones. We have also established monospecific assays for four lymphokines
in T cell supernatants, using mAbs in bioassays to increase specificity, and a new
monoclonal anti-IFN-7 antibody in an ELISA. Within a panel of 19 clones, our
results indicate that the differences between Thl and Th2 clones are even more
extensive than originally realized, and also show that for the four lymphokines
for which both RNA and protein or activity data were compared, a good
correlation exists between the two evaluation methods.
Materials and Methods
Cell Lines.
￿
The HT2 mouse T cell line (17) was obtained from S. Strober (Stanford
University, Stanford, CA), the MC/9 mouse mast cell line (18) and D9 T cell line (19)
from G. Nabel and H. Cantor (Harvard University, Boston, MA), the D10.G4.1 T cell
clone (20) from C. Janeway (Yale University, New Haven, CT), and the CDC-25 and
CDC-35 mouse T cell clones (21) from D. Parker (University ofMassachusetts, Worcester,
MA). The production and maintenance of our antigen-specific mouse T cell clones have
been described elsewhere (13, 22). The P3X63Ag myeloma cells were obtained from the
American Type Culture Collection (ATCC, Rockville, MD).
Antibodies.
￿
The S4B6 anti-IL-2 hybridoma has been described previously (13). Purified
11 B11 anti-IL-4 mAb (23) was a kind gift of R. Coffman, DNAX. mAbs recognizing IFN-
y were derived from a Lewis rat after immunizing on eight sequential d with soluble
recombinant mouse IFN-7 (170 kg/injection). This rat was obtained from M. Kehry
(DNAX), and later boosted with IFN-y (100 ug) in CFA (Gibco Laboratories, Grand
Island, NY). After 21 d, the rat was boosted with 100 wg IFN-y without adjuvant. 3 d
later, the spleen cells were fused with P3X63Ag myeloma cells using 50% polyethylene
glycol (Sigma Chemical Co., St. Louis, MO) (24). Antibodies directed against IFN-y were
identified by ELISA testing of supernatants. Nine of these were able to block the biological
activity of IFN-7 in two different bioassays: the effect of IFN-7 on proliferation of the
NFS60 cell line (13) and the inhibition by IFN-y of the enhancement of IgE synthesis by
IL-4 (25). XMG1 .2 is a rat IgGl mAb that is effective in both ELISA and blocking assays.
Affinity-purified rabbit anti-IFN-7 polyclonal antibodies were obtained by passing serum
from rabbits immunized with recombinant mouse IFN-y over a solid-phase immunoad-
sorbent column containing IFN-y and eluting the anti-IFN-y-specific antibodies.
Labeled DNA Probes.
￿
The coordinates of the DNA probes used for hybridization were
as follows: IL-2, nucleotides 498-570 (26); IL-3, 469-528 (27); IL-4, 445-498 (28); IL-
5, 404-461 (29); granulocyte/macrophage colony-stimulating factor (GM-CSF), 549-639
(30); IFN-'y, 900-989 (31); lymphotoxin (LT), 517-618 (32); TNF, 765-863 (33);
preproenkephalin (ppENK), 642-730 (34); TY5, 630-732 (Zurawski, G., personal com-
munication); P600, 91-691 (Brown, K. D., unpublished observations).
With the exception of IL-5 and P600, radioactive probes were prepared by fill-in
polymerization essentially following the procedure of Drouin (35). To label a given probe,
0 .4 ug each of a pair of synthetic oligonucleotides were mixed. These oligonucleotides
(ranging in length from 30 to 59 nucleotides) were synthesized on a DNA synthesizer
(model 380A; Applied Biosystems, Inc., Foster City, CA). The 3' terminal regions of
these synthetic strands were complementary for 6-15 bp. Fill-in synthesis was carried out
for 60 min at 37°C using 5 U of DNA polymerase (Klenow fragment; IBI, Miami, FL) in
the presence of 200,uCi each of a-[s2P]dCTP and a-["P]dATP (6,000 Ci/mmol, Amer-
sham Corp., Arlington Heights, IL) and 0.01 mM unlabeled dATP and 0.1 mM unlabeled
dGTP and dTTP in a total volume of 70 til Klenow reaction buffer (35). The IL-5 probeCHERWINSKI ET AL.
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was end-labeled essentially by the kinase procedure described by Maniatis et al. (36). A
synthetic 55-residue oligonucleotide (0.4 14g) was incubated for 60 min at 37 °C with 5 U
of T4 polynucleotide kinase (IBI) in the presence of 100 ;Ci of y-[s2P]ATP (6,000
Ci/mmol, Amersham Corp.) and kinase buffer in a volume of 70 j1. The P600 DNA
fragment (a 600-bp Pst I restriction fragment of the parental cDNA clone) was purified
from a Pst I restriction digest by PAGE, and recovered from the gel by the method of
Maxam and Gilbert (37). Radioactively labeled P600 was prepared using the hexanucle-
otide-primed labeling kit (RPN-1601; Amersham Corp.). The reaction mixture contained
200,uCi a-[s2P]CTP (6,000 Ci/mmol, Amersham Corp.) and 200 ng of P600 DNA. It was
incubated for 5 h at room temperature.
After all labeling reactions were complete, 20 Ag of carrier tRNA (Escherichia coli;
Sigma Chemical Co.) were added and unincorporated nucleotides were removed by two
passages on a spin column (1.5 ml of Sephadex G50), as described by Maniatis et al. (36).
Probes labeled by the fill-in or kinase methods had a specific activity of ^-100 uCi/kg
DNA, while probes labeled by hexanucleotide-primed synthesis had a specific activity of
-200 ,Ci/tcg DNA.
Cytoplasmic DotHybridization Analysis.
￿
Cytoplasmicmessenger RNAfractionsof Tcell
clones were prepared using the method of White and Bancroft (16). T cell clones were
harvested by centrifugation and resuspended at 2 X 106 cells/ml in RPMI 1640 (M. A.
Bioproducts, Walkersville, MD) plus 10% FCS (J . R. Scientific, Woodland, CA) containing
5 kg/ml Con A (Calbiochem-Behring Corp., La Jolla, CA) or medium without Con A as
a negative control. Cells were pelleted after 6 h of incubation by centrifugation (1,500 g,
5 min), resuspended in 1.0 ml PBS, and repelleted in a sterile, 1.5-ml tube . Cells were
lysed by resuspending in lysis buffer (0.14 M NaCl, 1.5 mM MgC12, 10 mM Tris-HCl, pH
8.6, 0.5% NP-40) at 4°C at a final concentration of 108 cells/ml. The suspension was
vortexed for 10 s and the nuclei were pelleted (13,000 g, 2.5 min). The resulting
cytoplasmic lysates were then transferred to a sterile 1.5-ml tube containing 0.3 volumes
of 20X SSC (IX SSC = 0.15 M NaCl, 0.015 M trisodium citrate) and0.2 volumes of 37%
(wt/wt) formaldehyde. The mixture was then incubated at 60 °C for 15 min and stored
in aliquots at -70°C. The same RNA preparations from each cell line were used for all
probes. Foranalysis, 15 Kl of each sample were titered by serial threefold dilutions in 15X
SSC into a 96-well flat-bottomed microtiter plate (Falcon Labware, Oxnard, CA) in 0.1
ml . Each dilution was applied with suction to a sheet of Nytran (0.45-fcm pore size;
Schleicher & Schuell, Inc., Keene, NH) supported on a filter paper (No. 3mmChr;
Whatman Inc., Clifton, NJ) using a 96-hole Minifold apparatus (Schleicher & Schuell,
Inc.). The Nytran paper was then baked (80°C, 2 h) and prehybridized for 4 h at 42°C
in 50% formamide (Bethesda Research Laboratories, Gaithersburg, MD), 6x SSC, 50
kg/ml E. coli tRNA (Sigma Chemical Co.), 0.2% (wt/vol) each of Ficoll (mol wt 400,000),
polyvinylpyrollidone, and BSA. The Nytran paper was hybridized with the s2P-labeled
DNA probe in the same mixture containing 50 ng probe/ml hybridization solution at
42'C for 24 h. After hybridization, the paper was washed two times for 15 min each at
room temperature in 2X SSC, then twice for 30 min each at 60°C in 2x SSC/0.5% SDS.
When the background was high, a final wash for 10 min at room temperature was done
in 0.2X SSC. The paper was then exposed to film using an intensifying screen and
quantitated by scanning with a laserdensitometer (Ultroscan XL; LKB Instruments, Inc.,
Gaithersburg, MD).
Lymphokines and T Cell Supernatants.
￿
Purified recombinant E. coli-derived mouse IL-
la was a generous gift of T. Kupper, Yale University. IFN-a and -,B were obtained from
Lee Biomolecular, San Diego, CA. Purified E. coli-derived recombinant mouse IL-2 and
IFN--y were provided by Schering Research, Bloomfield, NJ. Purified recombinant silk-
worm-derived IL-3 (37a) and purified recombinant yeast-derived GM-CSF (38) were
generous gifts of J. Schreurs, DNAX. Affinity-purified mammalian-derived mouse IL-4
was a kind gift of B. Castle and M. Howard, DNAX. Purified natural mouse IL-5 (B cell
growth factor II [BCGF-II], Bond, M. W., B. Shrader, T. R. Mosmann, and R. L.
Coffman, submitted for publication) was a kind gift of M. Bond and R. Coffman, DNAX.
T cell supernatants were prepared by incubating T cell clones with and without 5 acg/ml123 2 UNIQUE LYMPHOKINES OF TWO TYPES OF HELPER T CELL CLONE
Con A at 106 cells/ml in RPMI 1640 plus 10% FCS. The supernatants were harvested
after 24 h and tested for lymphokine activity.
Bioassays.
￿
IL-1 was assayed on the D10.G4.1 T cell clone (20) in the presence of I
jug/ml Con A. The assay medium was RPMI 1640 containing 0.05 mM 2-ME and 10%
FCS. Samples were diluted by twofold serial dilutions in 96-well, flat-bottomed plates
(Falcon Labware) in a volume of 0.05 ml. D10.G4.1 cells were added in a volume of 0 .05
ml at a final concentration of 104 cells/well and plates were incubated at 37 °C for 40 h.
Bioassays for IL-2, IL-3, T cell growth factor 2 (IL-4), and mast cell growth factor 2 (IL-
4) were modified from those described previously (13, 39). IL-2 and IL-4 were assayed
on the HT2 mouse T cell line in the presence of 5 ug/ml 11 B11 anti-IL-4 antibody or a
1 :500 dilution of S4B6 anti-IL-2 ascites fluid, respectively. IL-3 was assayed on the MC/9
mouse mast cell line in the presence of 5 jug/ml I IB11 anti-IL-4 antibody. In all cases, a
colorimetric method (40) was used to assess the extent of proliferation at the end of the
incubation period . This assay detects surviving and/or proliferating cells at the end of the
assay by their ability to cleave the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphen-
yltetrazolium bromide (MTT) to produce a colored product. 1 U of activity in the MTT
assay is defined as the amount of factor in 0 .1 ml which results in a signal that is 50% of
the maximum, using 2 x 103 HT2 cells/well, 10' MC/9 cells/well for 24 h, or 104
D10.G4.1 cells/well for 48 h .
ELISA Assayfor IFN-y.
￿
Samples were assayed for IFN-y by a two-site sandwich ELISA
using the rat anti-mouse IFN-y mAb XMG1 .2 and affinity-purified rabbit anti-mouse
IFN-y antibodies described above. Flexible PVC microtitre plates (Dynatech Laboratories,
Inc., Alexandria, VA) were coated with 100 wl of 1 Ng/ml XMG1 .2 in PBS for 2 h at
37'C, followed by blocking with 100 Al of 20% FCS and 0 .1% Tween 20 in PBS for 30
min at 37 ° C. Samples and recombinant mouse IFN-y standards were diluted in RPMI
plus 10% FCS, and 50 Al were added to each well. After 60 min incubation, the plates
were washed three times with PBS containing 0.1 % Tween 20 (PBST) and incubated with
50 ml affinity-purified rabbit anti-IFN-y (0.2 ttg/ml in PBST). After 60 min, the plates
were washed four times with PBST and incubated with 75 Al of a 1 :5,000 dilution ofgoat
anti-rabbit/horseradish peroxidase conjugate (TheJackson Laboratory, Bar Harbor, ME)
in PBST plus 0. I % BSA for 45 min. Trays were washed five times with PBST, and 100
,a] substrate (2,2'-azino(3-ethylbenzthiazoline sulfonic acid) [ABTS] 1 mg/ml, 0.003%
H202, 44 mM NaH2P04 - 7 H2O, 28 mM citric acid) was added. After 60 min at room
temperature, absorbance was measured at a wavelength of 405 nm and a reference of
490 nm on a VMAX microplate reader (Molecular Devices, Palo Alto, CA).
Results
T Cell Clones and DNA Probes.
￿
The distinctions between Th l and Th2 mouse
helper T cell clones based on patterns of lymphokine secretion, B cell help, and
ability to cause DTH have been described previously (13, 14). In this report we
used a panel of 19 T cell clones, which included examples derived from different
strains of mice having different antigen specificities and MHC haplotypes (Table
I) . The relative mRNA levels present in each of these T cell clones were assessed
by hybridization with radioactively labeled DNA probes for specific lymphokines.
All probes correspond to characterized lymphokine genes with the exception of
TY5 and P600 which are induction-specific cDNA clones isolated from a Th2
cDNA library (Brown, K. D., and G. Zurawski, unpublished data). The functions
of the induced proteins corresponding to TY5 and P600 are unknown, although
it is known that TY5 mRNA is expressed as a secreted protein (Mosmann, T.,
and S . Zurawski, unpublished data).
Lymphokine mRNA Synthesis ofThl and Th2 Clones.
￿
Fig. 1 shows representative
dot blots in which ThI and Th2 cytoplasmic mRNA preparations were hybrid-,
ized with synthetic DNA probes specific for IFN-y (A) or IL-4 (B). The IFN-yCHERWINSKI ET AL.
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TABLE I
Properties ofMouse T Cell Clones Usedfor mRNA Determination
* Chicken MHC(B) locusalleles on erythrocytes recognized by Tcell clone.
$Notapplicable.
s F(ab)s fragment of normal rabbit IgG.
Specificity notdetermined.
probe hybridized with the mRNA from the six Thl clones, but not with RNA
from the Th2 clones. In contrast, the DNA probe for IL-4 hybridized to the
mRNA from Th2 cells but not from the Thl clones tested. In both cases the
probes only hybridized to the RNA from cells induced with Con A, and not to
the RNA from uninduced cells, and this was true for all lymphokines tested in
this study.
Relative amounts of lymphokine mRNA were quantitated by scanning densi-
tometry of autoradiograms similar to the one shown in Fig. 1 . Values obtained
with uninduced T cell RNA were subtracted. The resultant plots of autoradi-
ographic density versus the cell equivalents of RNA applied were linear over the
ranges examined (data not shown). The amount of radioactivity hybridized to
RNA derived from 106 cells was calculated for each cell line. In cases where no
induced RNA was detectable, the result was expressed as the detection limit of
that particular probe. The value for each individual T cell clone was then
expressed as a percentage of the mean mRNA content, using the average of all
Thl and Th2 clones as the 100% value. Since these numbers were directly
related to the exposure time of the film and specific activity of each probe, we
could only compare relative mRNA levels between cell lines for a single probe .
This presentation of the results does not provide information on relative synthesis
levels between lymphokines.
Fig. 2, A and B, shows the mRNA profiles of IFN-y, IL-2, and LT for 19
T cell clone Mouse strain MHC
restriction Antigen specificity
Th 1
LB2-1 C57BL/6 H-216 CRBC-2+,13-,15+,21**
LB19-1 C57BL/6 H-216 CRBC-2+,13+,15+,21+
MD13-5.1 BALB/c H-21d CRBC-2+,13+,15+,21 -
MD13-10 BALB/c H-21d CRBC-2+,13+,15+,21+
GK15-1 CBA/J H-21" CRBC-2*,13',15+,21+
HDK-1 BALB/c H-2d KLH
M264-20 A,TL NA$ H-21d
M264-37 A.TL NA H-21d
Th2
D10.G4.1 AKR/J H-2I" Conalbumin
D9 C57BL/6 NA Unknown
MB2-1 C57BL/6 NA Spleen
HDZ-9 BALB/c NA H-216
HDK-2 BALB/c H-2d KLH
CDC-25 C3D2 H-21d/k F(ab)QNRGI
CDC-35 C3D2 H-2Id F(ab)2NRG
M264-39 A.TL NA H-21d
M386-13 CB6F1 NA CBA/Jl
M386-41 CB6F1 NA CBA/J1234 UNIQUE LYMPHOKINES OF TWO TYPES OF HELPER T CELL CLONE
FIGURE 1 . Autoradiogram show-
ing cytoplasmic dot hybridization of
IFN- ,y (A) and IL-4 (B) in Thl and
Th2 cells . Total RNA was extracted
from cellsand hybridized with radio-
active synthetic DNA for IFN--y or
IL-4 . RNAwasanalyzed fromT cells
with or without induction by ConA.
Threefold serial dilutions of RNA
startedat 5 x 10 5 cell equivalents per
dot .
differentT cell clones . The mRNA for these three lymphokines was present in
all induced Th l clones and undetectable in the Th2 clones tested (except for
the presence of small amounts ofIFN-y in the Th2 clone M264-39, and IL-2 in
M264-39 and M386-41) . In contrast, all inducedTh2 clones synthesizedmRNA
for IL-4 and IL-5 (Fig . 2, C and D), whereas all the Thl clones were negative
for these lymphokines. The P600 probe hybridized to the mRNA from all Th2
clones, whereas all except one Thl clone were negative . This pattern suggests
that P600 encodes a protein synthesized by inducedTh2 clones that is different
from any of the lymphokines examined in this study.
The mRNAs for IL-3, TY5, GM-CSF, TNF and ppENK were synthesized by
all theT cell clones tested . However, the levels of synthesis ofGM-CSF, ppENK,
TNF, andTY5 were higher in either ThI or Th2 clones . Fig. 2 (E and F) shows
that the average levels ofmRNA produced for GM-CSF, TNF, and TY5 were
greater for Thl clones . In contrast, the levels of ppENK mRNA were greater
for Th2 clones but were clearly detectable at lower levels in Th 1 clones (Fig. 2,
G andH) . The only lymphokine that did not show preferential synthesis by either
type of T cell clone was IL-3, which was synthesized in highly variable amounts
by all clones (Fig . 2, G andH; see also Table III) .CHERWINSKI ET AL .
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FIGURE 2 . Induced mRNA
synthesis patterns of Thl and
Th2 clones analyzed by cyto-
plasmic dot hybridization.To-
talRNApreparations from 19
Con A-stimulated T cell
clones were isolated and hy-
bridized with I I different 12p_
labeled DNA probes . Radio-
activity of each DNA probe
hybridized to RNA derived
from 10 6 cells of each clone
was determined after quanti-
tation of autoradiogram den-
sitometry. The 100% point
was set as the average value
over all clones for each indi-
vidual lymphokine probe .
Bars represent a percent of
this average value . Values ob-
tained with RNAfrom unstim-
ulated cells were subtracted
from the results shown. If no
inducedmRNA was detected,
the result was plotted as the
minimal detectable level.
Quantitative variation in mRNA levels could have been due to a combination
of differences in the degree of induction of a particular batch of cells, and
inherent differences in levels made by different types of clone. To gain further
information on the relative contributions o£ these two effects, the mRNA levels
for the Th2-preferential ppENK gene were plotted againstmRNA levels for the
ThI-preferential genes GM-CSF, TY5, and TNF, for each clone . The results in
Fig. 3 show that for each pair of probes, this analysis separates the T cell clones
into two clusters, and that the clones within each cluster correspond to the Thl
andTh2 sets of clones identified by the synthesis of the six type-specific lympho-
kines . Stated differently, there is a correlation between the levels of both
lymphokines within each major group of clones, so that Th2 clones that make
high enough amounts of TY5, TNF, or GM-CSF mRNA to overlap with the
lowest amounts made by the Thl clones, are also the clones that make larger
amounts of ppENK mRNA . This suggests that most of the overlap in mRNA
levels between Th l and Th2 clones for these mRNAs occurred as a result of
differences in the overall extent of induction, and that there are significant
differences between Th l and Th2 clones in the synthesis of each of these four
lymphokines . Similar plots for IL-2 and IL-4 indicate that the low levels of IL-2
found in twoTh2 clones also correlate with a high level of induction of IL-4 in
these two clones .
Functionally Monospecific Lymphokine Assays.
￿
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For each T cell clone, relative RNA levels of the Th2-preferential gene product
ppENK were plotted against the levels of the ThI-preferential gene products TNF (A), GM-
CSF (B), and TY5 (C) . Also shown is a plot ofthe ThI-specific gene product IL-2 vs. the Th2-
specific product IL-4 (D) . Relative RNA levels are expressed as percent average of all clones
tested. If no induced mRNA was detected, the result was plotted as the minimal detectable
level .
FIGURE 4 .
￿
HT2T cell growth factor assays. Di-
lutions of purified lymphokines and supernatants
from Con A-induced Thl and Th2 cells were
tested for their ability to support growth of HT2
cells : without antibody present, in the presence of
S4B6 anti-IL-2, in the presence of I IBI I anti-IL-
4, or in the presence or both I 1B11 and S4B6 .
Bars represent units ofactivity. Startingconcentra-
tions of purified lymphokines were : IL-1, 15,000
U/ml (D10/Con A proliferation assay) ; IL-2,
200,000 U/ml; IL-4, 50,000 U/ml (HT2 prolifer-
ation assay) ; IL-3, 30,000 U/ml (MC/9 prolifera-
tion assay) ; IL-5, 200 U/ml (BCL, proliferation
assay [41]) ; GM-CSF, 1,500 U/ml (NFS-60 prolif-
eration assay [13]) ; IFN-y, 0.1 wg/ml . LB2-1 (Thl)
and D10 (Th2) supernatants were obtained after
stimulation for 24 h with 5 wg/ml ConA at 5 x
10 6 cells/ml . The starting dilutions of the T cell
supernatants were 1 :4 in each assay.
abled us to assay a panel of different T cell clones for a large number of
lymphokines with relative precision . The disadvantage of this method is that it
detects mRNA and not secreted, biologically active proteins . To verify the
synthesis of active lymphokines, we used mAbs tó improve the specificity ofsome
commonly used bioassays by neutralizing unwanted activities .
Fig . 4 shows that HT2 proliferated in response to either IL-2, IL-4, or
supernatants from either a ThI or Th2 Con A-induced T cell clone, but not to
any of the other purified lymphokines tested . When the assay was supplementedCHERWINSKI ET AL .
￿
1237
FIGURE 5 .
￿
MC/9 growth factor assays . Dilu-
tions of purified lymphokines and Con A-in-
duced Thl and Th2 supernatants were tested
for their ability to support growth of MC/9
mast cells without antibody present, or in the
presence of lIBI l anti-IL-4 . Activities of pu-
rified lymphokines and starting dilutions of
Thl and Th2 supernatants were as described
in Fig. 4 .
with anti-IL-4 (IIB11) the responses of HT2 to IL-2 or the ThI supernatant
were unaffected whereas the apparent titers of the purified IL-4, and IL-4-
containing Th2 supernatant were reduced by ~1000-fold. Similarly, when the
HT2 assay was supplemented with anti-IL-2 (S4B6), the titers of IL-2, either
purified or in the Thl supernatant, were reduced and the titers of purified IL-
4 or Th2 supernatant were unaffected . Fig. 4 also shows the effect of supple-
menting the HT2 assay with both anti-IL-4 and anti-IL-2 . The titers of IL-2, IL-
4, and both Th l and Th2 supernatants were reduced . This suggests that the
responses of HT2 to the Th 1 and Th2 supernatants in these assays are only due
to the presence of either IL-2 or IL-4 .
By comparing the units of T cell growth factor obtained in the presence of
both antibodies with the units obtained in the presence of anti-IL-4 alone, the
amount of IL-2 activity in the supernatantcould be precisely evaluated . Similarly,
IL-4 titers could be evaluated from the comparison of titrations in the presence
of both antibodies, with results obtained with anti-IL-2 alone. In each case, a
very large excess of the other lymphokine will prevent reliable detection, unless
higher concentrations of blocking antibody are used .
We used the MC/9 mouse mast cell target line to assay for the bioactivity of
IL-3 . Fig. 5 illustrates that MC/9 proliferated in response to purified IL-3, IL-
4, and both ThI and Th2 supernatants but not to any of the other lymphokines
tested . Data from HPLC separations of Th 1 andTh2 supernatants also indicate
that IL-3 and IL-4 are the only lymphokines that stimulate MC/9 proliferation
(unpublished data) . When IL-3 and IL-4 are both present, as in the Th2
supernatant, the maximum proliferation rate of MC/9 is greater than in the
presence of either factor alone (13, 42) . Supplementing the assay with anti-IL-4
antibody reduces the response to IL-4 and thus decreases the saturation level of
the Th2 supernatant, but has no effect on the response of MC/9 to IL-3 or Thl
supernatant (not shown) . Since the Th2 supernatant also contains IL-3, the units
of activity detected are not altered in this case (Fig . 5) .
It is important to note that these assays are only demonstrated to be monospe-
cific for lymphokines present in the supernatants of induced Thl and Th2
clones . We do not rule out the possibility that other factors, not present in these
supernatants, might affect the proliferative response of the target cells .1238 UNIQUE LYMPHOKINES OF TWO TYPES OF HELPER T CELL CLONE
TABLE II
Specificity of Detection ofIFN-y by ELISA
To assay specifically for IFN-y, an ELISA was developed using a monoclonal
rat anti-IFN-y antibody (XMG1.2) and affinity-purified polyclonal rabbit anti-
IFN-y antibodies. Only IFN-y was detected; IFN-a, IFN-a, IL-2, and GM-CSF
failed to give a significant signal at concentrations of purified protein up to 1
Ag/ml (Table II). D10 (Th2) supernatant also provided no detectable signal,
signifying that not only was IFN-y absent but also that the assay did not show
crossreactivity with any Th2 lymphokines. The minimum significant signal was
regarded as two times the signal elicited by assay medium alone. The limit of
detectability in this ELISA normally falls between 0.05 and 0.1 ng/ml IFN-y
(data not shown). Supernatants from Con A-induced Thl. cells could typically
contain 1,500-6,000 ng/ml IFN-y, whereas levels in uninduced Thl superna-
tants as well as supernatants from both induced and uninduced Th2 cells fell
below the sensitivity limit. Thus the IFN-y-specific ELISA can be used to detect
IFN-y in T cell supernatants over a range of nearly 105-fold.
Correlation Between mRNA Synthesis and Protein Secretion. To test whether
there was any correlation between the levels oflymphokine specific mRNAs and
the corresponding secreted proteins, we prepared Con A-induced supernatants
of all the T cell clones used in RNA studies to test in our lymphokine assays.
Total cell mRNA preparations (6 h) and the supernatants (24 h) were prepared
from the same batch ofcells in all cases. The supernatants were analyzed for IL-
2, IL-3, IL-4, and IFN-y activities in the assays described above. Results were
calculated foreach individual cloneas unitsofactivity for bioassays ornanograms
per milliliter of IFN-y in the ELISA, and were then converted to percent of
averageofall clones tested. The resultsobtained in this way were then compared
with the mRNA values obtained by dot-blotting analysis for each corresponding
lymphokine. Table III shows that there was generally good agreement between
the two measures of lymphokine expression . As expected, the low-level expres-
sion of, for example, IL3, was detected only by the bioassay.
Combining the mRNA, protein, and bioactivity data, the following consensus
patterns oflymphokine synthesisemerge. Compared with the average expression
levels ofall T helper clones tested, Th1 clones express high levels ofIL-2, IFN-y,
LT, GM-CSF, TNF, TY5, and IL-3; low levels ofppENK; and no IL-4, IL-5, or
Lymphokines
IFN-y per
100 Fag protein
IFN-y/ml
Induced Unin-
duced
ng
IFN-y 100
IFN-a <0.003
IFN-,B <0.003
IL-2 <0.01
GM-CSF <0.01
Thl (LB2-1) 4,920 <0.1
Th2 (D10) <0 .1 <0.1CHERWINSKI ET AL.
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TABLE III
Correlation bettoeen Lymphokine RNA Synthesis andProtein Secretion
* IFN-y levels in supernatant determined by ELISA assay, expressed as the percent of the average
of all clones.
$Cytoplasmic RNA levels, determined by the dot blot procedure, expressed as a percent of the
averageof all clones.
*Supernatant bioactivity levels, determined by the bioassays shown in Figs. 4 and 5, expressed as a
percent of the average ofall clones.
P600. In contrast, Th2 clones express high levels of IL-4, IL-5, P600, ppENK,
and IL-3; low levels of GM-CSF and TNF; and no detectable IL-2, IFN-y, or
LT.
Discussion
We have chosen in these studies to use cytoplasmic dot hybridization as the
most effective way to determine the lymphokine synthesis patterns. The com-
plexity of current bioassays means that only a few lymphokines can be unambig-
uously assayed without complex procedures, and so the range of lymphokines
that can be stringently identified by bioassay is less than with the RNA dot-blot
method. The ability of the probe to hybridize to homologous but nonidentical
sequences in RNA could give an occasional false-positive reaction, although this
possibility is minimized by using relatively short DNA probes (50-100 bases),
and by confirming results with a second probe in certain cases. The principle
drawback ofthe RNA procedure is that the presence of mRNA does not prove
that the corresponding protein is synthesized and secreted as an active lympho-
kine.
We measured both RNA and protein levels offour lymphokines (IL-2, IL-3,
IL-4, and IFN-y), and the results correlate well. This supports the validity ofthe
T cell
IFN-y
ELISA* RNAt
IL-2
Bioassay4 RNA
IL-3
Bioassay RNA
IL-4
Bioassay RNA
L132-1 279 267 236 341 36 199 <0.04 <7
LB19-1 376 268 113 158 20 71 <0.04 <1
MD13-5.1 108 236 192 367 15 68 <0.04 <7
MD13-10 209 143 56 13 2 5 <0.04 <1
GK15-1 249 284 95 219 14 32 <0.04 <5
HDK-1 191 228 183 74 28 32 <0.04 <7
M264-20 78 77 166 92 3 21 <0.04 <5
M264-37 220 209 291 187 77 327 <0.04 <5
H66-61 135 79 513 319 108 207 <0.04 <5
D10 <0 .04 <4 <0.1 <9 220 201 207 222
D9 <0 .04 <4 <0.1 <9 2 <4 10 9
MB2-1 <0.04 <4 <0.1 <9 27 <4 459 299
HDZ-9 <0.04 <4 4 <9 234 135 186 131
HDK-2 <0.04 <4 <0.1 <9 3 <4 36 10
CDC-25 <0.04 <5 <0.1 <9 141 96 258 158
CDC-35 <0 .04 <5 <0 .1 <9 43 26 171 61
M264-39 54 68 21 20 190 298 261 461
M386-13 <0.04 <4 <0.1 <9 8 <5 63 49
M386-41 <0.04 <4 30 43 100 163 248 4571240 UNIQUE LYMPHOKINES OF TWO TYPES OF HELPER T CELL CLONE
RNA procedure, and suggests that at least for these four lymphokines, transla-
tional control does not significantly influence the relative levels of lymphokine
produced. In addition, we have limited data that suggest that the RNA results
for IL-5, met-enkephalin, TY5, and GM-CSF are also true at the level of secreted
proteins (34; Mosmann, T., M . Bond, and R. Coffman, unpublished results). In
general, the RNA data reported here are in agreement with the results of
probing of cDNA libraries from a Thl clone, LB2-1 (26), and a Th2 clone, D9
(27; Brown, K . D., unpublished results). The latter results are particularly
important in confirming the synthesis of TNF by both types of T cell clone, since
TNF has been generally regarded as a monocyte but not T cell product (43) .
The patterns of synthesis of TNF and IL-5 by the T cell clones in our panel have
also been confirmed using second-site synthetic probes complementary to other
regions of the mRNA (unpublished results).
The T cell clones assayed in this study were stimulated with Con A to induce
lymphokine synthesis. In a previous study (13), we showed that for several clones,
including both Thl and Th2 examples, the same lymphokines (IL-2, IL-3, IL-4,
and IFN-7) were produced in response to either Con A or antigen plus APCs .
We have carried out preliminary experiments using antigen or Con A plus PMA
stimulation, and find that antigen stimulation gives lower lymphokine mRNA
levels, and Con A plus PMA gives higher levels than Con A alone. In neither
case was there an alteration in the patterns of lymphokine synthesis (our unpub-
lished results). The mRNA and supernatant samples for this study were taken 6
and 24 h, respectively, after induction. These times had previously been found
to be optimal for several lymphokines (our unpublished results). Levels of IL-2,
IL-3, IL-4, and IFN-7 activity in supernatants correlate well with the RNA data,
indicating that the major Thl/Th2 differences in synthesis of IL-2, IFN-'Y, and
IL-4 are not due to differences in induction kinetics. There is limited data
suggesting that this is also true for IL-5 and ppENK.
In previous experiments, we noted that IL-2 mRNA or protein synthesis did
not always occur in response to stimulation, in contrast to IL-3 and IFN-7
synthesis. In experiments to evaluate lymphokine mRNA synthesis, two clones
(MD13-10 and LB19-1) did not synthesize IL-2, although their synthesis of all
other lymphokine mRNAs showed the typical Thl pattern. In a subsequent
experiment (shown in Fig. 2), IL-2 was synthesized at significant levels by these
two clones. The synthesis of the other lymphokines in our test panel has not
shown this variability, which suggests that IL-2 synthesis may be regulated
somewhat differently from other lymphokines.
While the Th l and Th2 patterns of lymphokine synthesis are remarkably
distinct, some of the 19 clones in our test panel (especially M264-39) did not
show absolute agreement with the Th1 and Th2 consensus patterns. At present,
it is not clear if this represents real heterogeneity of T cells, or if the in vitro T
cell clones show some variation from normal patterns. Some of the clones in the
panel have been in culture for several months, and are not completely stable
with respect to Lyt-1 or IL-2 expression, although the synthesis of other cell-
surface antigens and lymphokines appears to be stable over several months.
The results obtained with this panel of T cell clones suggest that the syntheses
of IL-2, IFN-7, LT, IL-4, IL-5,and P600 are mediated predominantly or entirelyCHERWINSKI ET AL.
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by one or the other of the T cell types. In contrast, GM-CSF, TNF, TY5, and
ppENK are synthesized in larger amounts by one subset, but in each case the
other subset also synthesizes detectable amounts. We do not yet know the
significance of these smaller differences in lymphokine synthesis between the
clones, although the results of the two dimensional plots (Fig. 3) suggest that
these differences are genuine.
An important question arising out of the separation of Th cell clones into two
subsets is whether the same two sets of lymphokine synthesis patterns exist in
vivo. Evidence from the rat suggests that two types of CD4' Th cell exist, since
OX22+ cells produce the majority of IL-2 synthesized by Th cells, and OX22-
cells provide the majority of B cell help (15) . These data, obtained with normal
spleen cells, are consistent with the evidence derived from mouse T cell clones.
Further evidence (reviewed in reference 44) also suggests that Thl and Th2
cells may exist in normal lymphocyte populations.
In view of the major differences between Thl and Th2 lymphokine synthesis
patterns, it is perhaps not surprising that these two types of clone also differ
markedly in function. When injected into the footpads of naive mice, Thl but
not Th2 clones induce an antigen-dependent swelling reaction with the charac-
teristics of DTH (14). Only clones producing IFN-y and LT, presumably corre-
sponding to our Thl clones, are capable of killing target cells (45). Although
both types of clone can provide both linked and unlinked help for antibody
production by B cells (21, 22), the nature of the help may differ. In particular,
only Th2 clones provide strong help for IgE responses (Coffman, R., and T .
Mosmann, unpublished data). This is probably related to the production of IL-4
by Th2 clones, and IFN-y by Thl clones, since IL-4 or monoclonal anti-IFN-y
enhances IgE responses, whereas IFN-y or monoclonal anti-IL-4 suppresses IgE
responses, both in vitro (25; Coffman, R., personal communication) and in vivo
(3, 46). In contrast to the enhancement of IgE synthesis by Th2 clones, IgG2a
may be positively regulated by Th 1 clones, since IFN-y is now known to enhance
IgG2a production both in vitro (47) and in vivo (Finkelman, F. D., I. Katona, T.
R. Mosmann, and R. L. Coffman, manuscript submitted for publication).
Summary
Lymphokine synthesis patterns of a panel of 19 T cell clones have been
evaluated, using mRNA hybridization methods to examine I 1 different mRNAs
induced by Con A. The two types of CD4'' Th cell clone described previously
(13) were clearly distinguished by this procedure, and the differences between
the two types have now been extended to six induced products. With minor
exceptions, only Thl clones synthesized mRNA for IL-2, IFN-y, and lympho-
toxin, and only Th2 clones synthesized mRNA for IL-4, IL-5, and another
induced gene, P600. Four more induced products were expressed preferentially
but not uniquely by one or another type of clone: mRNAs for GM-CSF, TNF,
and another induced, secreted product (TY5) were produced in larger amounts
by Th l clones, whereas preproenkephalin was preferentially expressed by Th2
clones . IL-3 was produced in similar amounts by both types of clone. mAbs were
used to establish three bioassays that were functionally monospecific for IL-2,
IL-3, and IL-4, and a new anti-IFNy mAb, XMG1 .2, was used to establish an1242 UNIQUE LYMPHOKINES OF TWO TYPES OF HELPER T CELL CLONE
ELISA for IFN-y. These four assays were used to show that secreted protein
and mRNA levels correlated well for all cell lines. The implications of these
findings for normal T cells are discussed.
We thank Gerard Zurawski for helpful discussions and sequence information, Pat Gray
for sequence information, Karl Pope for synthesis of DNA probes, and Annie Fong and
Bob Coffman for helpful discussions.
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